facebook
TradedTraded
    Home
    Deals
    Newsletter
    Articles
    PropTech
    Partners


Messages

Go Pro
+ Submit+ Submit
All Deals
July 7, 2026 - Deals

Bespoke Labs Raises $40 Million In Seed And Series A Funding Led By Wing VC And 8VC

Property Image
Bespoke Labs, an AI agent training platform, raised $40 million across its seed and Series A funding rounds to expand its research team, scale its environment-building infrastructure, and accelerate business growth. The Series A was led by Wing VC with participation from Mayfield, The House Fund, dbt Labs CEO Tristan Handy, and angel investors from Anthropic, OpenAI, and Meta, while the seed round was led by 8VC with participation from Jeff Dean, Resolve AI CEO Spiros Xanthos, DevRev CEO Dheeraj Pandey, and others. Founded in 2024, the company is led by co-founder and CEO Mahesh Sathiamoorthy, with co-founder Alex Dimakis serving as Chief Science Officer. FOUNDERS: Mahesh Sathiamoorthy & Alex Dimakis INVESTORS: Wing VC, Mayfield, The House Fund, 8VC, Jeff Dean, Tristan Handy, Spiros Xanthos, Dheeraj Pandey, Anthropic, OpenAI & Meta ROUND: Seed & Series A AMOUNT: $40,000,000 HQ: Mountain View, California #VentureCapital #BespokeLabs #MaheshSathiamoorthy #AlexDimakis #TradedVC

Property Image
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC